Gene · 11284
Papers2,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome-wide association study identifies novel candidate susceptibility genes for migraine. | HGG Adv | 2023 | 37415806 | PubTator, text mining | PubMed |
| CRIC-seq protocol for in situ profiling of proximal RNA-RNA contacts associated with RNA-binding proteins. | STAR Protoc | 2023 | 37405924 | PubTator, text mining | PubMed |
| PEPseq quantifies transcriptome-wide changes in protein occupancy and reveals selective translational repression after translational stress. | Nucleic Acids Res | 2023 | 37395449 | PubTator, text mining | PubMed |
| DNA-PK is activated by SIRT2 deacetylation to promote DNA double-strand break repair by non-homologous end joining. | Nucleic Acids Res | 2023 | 37395399 | PubTator, text mining | PubMed |
| Repair of topoisomerase 1-induced DNA damage by tyrosyl-DNA phosphodiesterase 2 (TDP2) is dependent on its magnesium binding. | J Biol Chem | 2023 | 37392847 | PubTator, text mining | PubMed |
| Targeting lysine-specific demethylase 1 (KDM1A/LSD1) impairs colorectal cancer tumorigenesis by affecting cancer cells stemness, motility, and differentiation. | Cell Death Discov | 2023 | 37385999 | PubTator, text mining | PubMed |
| A Multimodal Approach towards Genomic Identification of Protein Inhibitors of Uracil-DNA Glycosylase. | Viruses | 2023 | 37376646 | PubTator, text mining | PubMed |
| Enhanced mitochondrial G-quadruplex formation impedes replication fork progression leading to mtDNA loss in human cells. | Nucleic Acids Res | 2023 | 37351621 | PubTator, text mining | PubMed |
| A critical spotlight on the paradigms of FFPE-DNA sequencing. | Nucleic Acids Res | 2023 | 37351572 | PubTator, text mining | PubMed |
| PARP-1: a critical regulator in radioprotection and radiotherapy-mechanisms, challenges, and therapeutic opportunities. | Front Pharmacol | 2023 | 37351512 | PubTator, text mining | PubMed |
| The role of aging and brain-derived neurotrophic factor signaling in expression of base excision repair genes in the human brain. | Aging Cell | 2023 | 37334527 | PubTator, text mining | PubMed |
| The CSB chromatin remodeler regulates PARP1- and PARP2-mediated single-strand break repair at actively transcribed DNA regions. | Nucleic Acids Res | 2023 | 37326017 | PubTator, text mining | PubMed |
| Explore the dominant factor in prime editing via a view of DNA processing. | Synth Syst Biotechnol | 2023 | 37325180 | PubTator, text mining | PubMed |
| Molecular mechanisms of tumor resistance to radiotherapy. | Mol Cancer | 2023 | 37322433 | PubTator, text mining | PubMed |
| Exploring the mechanism of BK polyomavirus-associated nephropathy through consensus gene network approach. | PLoS One | 2023 | 37319163 | PubTator, text mining | PubMed |
| Temozolomide Sensitizes ARID1A-Mutated Cancers to PARP Inhibitors. | Cancer Res | 2023 | 37306706 | PubTator, text mining | PubMed |
| Deficit of homozygosity among 1.52 million individuals and genetic causes of recessive lethality. | Nat Commun | 2023 | 37301908 | PubTator, text mining | PubMed |
| Biosensors with Metal Ion-Phosphate Chelation Interaction for Molecular Recognition. | Molecules | 2023 | 37298870 | PubTator, text mining | PubMed |
| IGFBP7 Fuels the Glycolytic Metabolism in B-Cell Precursor Acute Lymphoblastic Leukemia by Sustaining Activation of the IGF1R-Akt-GLUT1 Axis. | Int J Mol Sci | 2023 | 37298628 | PubTator, text mining | PubMed |
| The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways. | Int J Mol Sci | 2023 | 37298600 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11284/papers?page=12